Patrick Waters

• Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.

  Kim SM. et al, (2017), Mult Scler, 23, 1104 - 1111

• Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

  Lang B. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 353 - 361

• G2A1B3AA receptor antibodies and their clinical associations.

  Waters PJ. and Irani SR., (2017), Neurology, 88, 1010 - 1011

• Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

  Tackley G. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 165 - 169

• Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

  Juryńczyk M. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 132 - 136

• Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

  Rivas JR. et al, (2017), Acta Neuropathol, 133, 43 - 60

• Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.

  Kaneko K. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 1257 - 1259

• Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

  Waters P. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 1005 - 1015

• Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies.

  Hacohen Y. et al, (2016), Dev Med Child Neurol, 58, 836 - 841

• Neurexin-3α: A new antibody target in autoimmune encephalitis.

  Waters PJ. and Irani SR., (2016), Neurology, 86, 2222 - 2223

• Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.

  Lee JY. et al, (2016), Ann Clin Transl Neurol, 3, 443 - 454

• Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study.

  Moloney TC. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 676 - 677

• Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.

  Wright S. et al, (2016), Epilepsia, 57, 823 - 831

• Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.

  Tackley G. et al, (2016), Mult Scler Relat Disord, 7, 21 - 25

• A clinical approach to diagnosis of autoimmune encephalitis.

  Graus F. et al, (2016), Lancet Neurol, 15, 391 - 404

• Antibody to Myelin Oligodendrocyte Glycoprotein in Adults with Inflammatory Demyelinating Disease of The CNS

  Kim SM. et al, (2016), MULTIPLE SCLEROSIS JOURNAL, 22, 403 - 403

• Antibodies to AMPA receptors in Rasmussen's encephalitis.

  Nibber A. et al, (2016), Eur J Paediatr Neurol, 20, 222 - 227

• Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

  Piccolo L. et al, (2016), J Neurol, 263, 370 - 379

• Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

  Nour MM. et al, (2016), Neurology, 86, 79 - 87

• Detection methods for neural autoantibodies.

  Waters P. et al, (2016), Handb Clin Neurol, 133, 147 - 163

• Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.

  Horellou P. et al, (2015), J Neuroimmunol, 289, 1 - 7

• Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

  Kim SM. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Antibodies to aquaporin-1 are not present in neuromyelitis optica.

  Schanda K. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• GLYCINE RECEPTOR ANTIBODY-A MARKER FOR NMO/ NON-MS DEMYELINATION?

  Hamid S. et al, (2015), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86

• Relapsing central nervous system demyelination in children with myelin oligodendrocyte glycoprotein (MOG) antibodies

  Hacohen Y. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 88 - 89

• Neuromyelitis optica spectrum disorders and polyautoimmunity

  Correia AS. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 655 - 656

• Clinical phenotypes of pediatric and adult patients with anti-MOG antibodies

  Sato DK. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 87 - 88

• Astrocyte and myelin injury in neuroinflammatory disorders with myelin oligodendrocyte glycoprotein or aquaporin-4 antibody positive cerebrospinal fluid

  Kaneko K. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 134 - 135

• Update on biomarkers in neuromyelitis optica.

  Melamed E. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.

  Kitley J. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.

  Gozzard P. et al, (2015), Neurology, 85, 235 - 239

• International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

  Wingerchuk DM. et al, (2015), Neurology, 85, 177 - 189

• MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

  Waters P. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.

  Morris KA. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Autoantibodies against MOG in Neuromyelitis Optica Spectrum Disorders

  Sato DK. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 804 - 805

• Paediatric neuromyelitis optica: Clinical, MRI of the brain and prognostic features

  Absoud M. et al, (2015), Journal of Neurology, Neurosurgery and Psychiatry, 86, 470 - 472

• Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.

  Absoud M. et al, (2015), J Neurol Neurosurg Psychiatry, 86, 470 - 472

• Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.

  Hacohen Y. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome.

  Pillai SC. et al, (2015), Pediatrics, 135, e974 - e984

• Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.

  Pettingill P. et al, (2015), Neurology, 84, 1233 - 1241

• Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.

  Symmonds M. et al, (2015), Neurology, 84, 1177 - 1179

• Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?

  Aboulenein-Djamshidian F. et al, (2015), J Neuropathol Exp Neurol, 74, 194 - 197

• NEURONAL ANTIBODIES IN PAEDIATRIC EPILEPSY: CLINICAL FEATURES AND LONG-TERM OUTCOMES

  Wright S. et al, (2015), EPILEPSIA, 56, 252 - 253

• Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.

  Thebault S. et al, (2015), PLoS One, 10

• Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses.

  Lancaster E. et al, (2015), Ann Neurol, 77

• Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders

  Cheng F. et al, (2014), JOURNAL OF NEUROIMMUNOLOGY, 275, 76 - 77

• Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres

  Waters P. et al, (2014), JOURNAL OF NEUROIMMUNOLOGY, 275, 15 - 15

• RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES

  Elsone L. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

  Nour M. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• MOG-IGG IN NMO AND NMO-LIKE DISORDERS

  Luppe S. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• Evaluation of aquaporin-4 antibody assays.

  Waters PJ. et al, (2014), Clin Exp Neuroimmunol, 5, 290 - 303

• Complement activation in patients with neuromyelitis optica.

  Nytrova P. et al, (2014), J Neuroimmunol, 274, 185 - 191

• Laquinimod prevents NMOIg-induced disease exacerbation in a model of neuromyelitis optica

  Argaw AT. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 239 - 239

• Autoantibodies against MOG and aquaporin-4 identify distinct neuromyelitis optica spectrum disorders subgroups

  Sato DK. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 24 - 25

• Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

  Carvajal-González A. et al, (2014), Brain, 137, 2178 - 2192

• Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy.

  Zuliani L. et al, (2014), Neurol Neuroimmunol Neuroinflamm, 1

• Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

  Kezuka T. et al, (2014), Neurology, 83

• Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.

  Kitley J. et al, (2014), JAMA Neurol, 71

• PATHOGENIC POTENTIAL OF ANTIBODIES DIRECTED AGAINST AMPAR AND GABA(B)R IN AUTOIMMUNE ENCEPHALITIS

  Nibber A. et al, (2014), EPILEPSIA, 55, 9 - 9

• NMDA receptor antibodies associated with distinct white matter syndromes.

  Hacohen Y. et al, (2014), Neurol Neuroimmunol Neuroinflamm, 1

• Anti-MOG Antibody Seropositive Patient Successfully Treated with Intermittent Rituximab Infusion

  Kim W. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 955 - 955

• Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders

  Sato DK. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 943 - 943

• The impact of neuromyelitis optica spectrum disorder on pregnancy outcome

  Nour MM. et al, (2014), EUROPEAN JOURNAL OF NEUROLOGY, 21, 758 - 758

• The impact of neuromyelitis optica spectrum disorder on pregnancy outcome

  Nour MM. et al, (2014), JOURNAL OF NEUROLOGY, 261, S487 - S487

• Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.

  Kim SM. et al, (2014), BMC Neurol, 14

• Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.

  Hacohen Y. et al, (2014), J Neurol Neurosurg Psychiatry, 85, 456 - 461

• Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.

  Saadoun S. et al, (2014), Acta Neuropathol Commun, 2

• Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study

  Kitley J. et al, (2014), JAMA NEUROLOGY, 71, 276 - 283

• Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

  Kitley J. et al, (2014), JAMA Neurol, 71, 276 - 283

• Investigation of neuronal autoantibodies in two different focal epilepsy syndromes.

  Ekizoglu E. et al, (2014), Epilepsia, 55, 414 - 422

• Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

  Sato DK. et al, (2014), Neurology, 82, 474 - 481

• N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse.

  Hacohen Y. et al, (2014), Mov Disord, 29, 90 - 96

• N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse

  Hacohen Y. et al, (2014), Movement Disorders, 29, 90 - 96

• Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.

  Min JH. et al, (2014), PLoS One, 9

• Complement activation in patients with neuromyelitis optica

  Nytrova P. et al, (2014), Journal of Neuroimmunology, 274, 185 - 191

• Autoantibody biomarkers in childhood-acquired demyelinating syndromes: Results from a national surveillance cohort

  Hacohen Y. et al, (2014), Journal of Neurology, Neurosurgery and Psychiatry, 85, 456 - 461

• Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.

  Woodhall M. et al, (2013), J Neurol Sci, 335, 221 - 223

• Factor H interferes with C1q-A beta interaction, and dampens classical pathway activation and subsequent neuroinflammatory response

  Nayak A. et al, (2013), MOLECULAR IMMUNOLOGY, 56, 269 - 269

• Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.

  Suleiman J. et al, (2013), Epilepsia, 54, 2091 - 2100

• Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

  Kitley J. et al, (2013), JAMA Neurol, 70, 1375 - 1381

• Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks

  Murchison AG. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 329 - 329

• Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies

  Sato D. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 81 - 81

• Neuromyelitis optica IgG causes placental inflammation and fetal death in mice

  Saadoun S. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 370 - 371

• Laquinimod prevents NMOIg-induced disease exacerbation in a model of neuromyelitis optica

  Argaw A. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 134 - 134

• Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

  Irani SR. et al, (2013), Brain, 136, 3151 - 3162

• Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain

  Saadoun S. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 134 - 135

• C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica

  Nytrova P. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 539 - 540

• Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders

  Kitley J. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 83 - 84

• Neuromyelitis optica IgG causes placental inflammation and fetal death.

  Saadoun S. et al, (2013), J Immunol, 191, 2999 - 3005

• GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction

  Lesca G. et al, (2013), Nature Genetics, 45, 1061 - 1066

• GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.

  Lesca G. et al, (2013), Nat Genet, 45, 1061 - 1066

• Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

  Kitley J. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 918 - 921

• Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.

  Kim SM. et al, (2013), Mult Scler, 19, 1060 - 1067

• Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.

  Min JH. et al, (2013), J Clin Neurosci, 20, 938 - 942

• Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

  Hacohen Y. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 748 - 755

• Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

  Sato DK. et al, (2013), Neurology, 80, 2210 - 2216

• Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.

  Brenner T. et al, (2013), Epilepsia, 54, 1028 - 1035

• Pathogenic mechanisms of glycine receptor antibodies and their clinical spectrum

  Carvajal A. et al, (2013), JOURNAL OF NEUROLOGY, 260, S21 - S21

• INVESTIGATION OF AUTO-ANTIBODIES IN PATIENTS DIAGNOSED WITH FOCAL EPILEPSY

  Ekizoglu E. et al, (2013), EPILEPSIA, 54, 133 - 133

• IDENTIFICATION OF A FIRST AND MAJOR GENE FOR ACQUIRED EPILEPTIC APHASIA (LANDAU-KLEFFNER SYNDROME) AND RELATED CHILDHOOD FOCAL EPILEPSIES AND ENCEPHALOPATHIES WITH SPEECH AND LANGUAGE DYSFUNCTION

  Lesca G. et al, (2013), EPILEPSIA, 54, 15 - 16

• Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies.

  Damásio J. et al, (2013), JAMA Neurol, 70, 498 - 501

• Factors associated with the AQP4-Ab positivity in patients with longitidunally extensive transverse myelitis (LETM): possible role of asymptomatic VEP abnormality

  Kim J-Y. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 663 - 663

• Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system

  Kim J-Y. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 658 - 658

• The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders

  Sato D. et al, (2013), NEUROLOGY, 80

• Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies

  Cavus F. et al, (2013), NEUROLOGY, 80

• Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica

  Kitley J. et al, (2013), NEUROLOGY, 80

• Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses.

  Shugaiv E. et al, (2013), Eur Neurol, 69, 257 - 262

• Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

  Hacohen Y. et al, (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84, 748 - 755

• MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.

  Koneczny I. et al, (2013), PLoS One, 8

• Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies

  Kitley J. et al, (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84, 918 - 921

• Acute measles encephalitis in partially vaccinated adults.

  Fox A. et al, (2013), PLoS One, 8

• Glycine receptor antibodies: Clinical spectrum and pathogenic mechanisms of the antibodies

  Carvajal A. et al, (2012), JOURNAL OF NEUROIMMUNOLOGY, 253, 91 - 91

• Factors associated with the AQP4-Ab positivity in patients with longitudinally extensive transverse myelitis (LETM): Possible role of asymptomatic VEP abnormality

  Park KS. et al, (2012), JOURNAL OF NEUROIMMUNOLOGY, 253, 32 - 33

• Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system

  Park KS. et al, (2012), JOURNAL OF NEUROIMMUNOLOGY, 253, 32 - 32

• The search for new antigenic targets in myasthenia gravis.

  Cossins J. et al, (2012), Ann N Y Acad Sci, 1275, 123 - 128

• Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.

  Vincent A. et al, (2012), Ann N Y Acad Sci, 1274, 92 - 98

• Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.

  Min JH. et al, (2012), Acta Neurol Scand, 126, 287 - 291

• Factors associated with the aquaporin-4 antibodies positivity in patients with longitidunally extensive transverse myelitis: possible role of asymptomatic visual-evoked potential abnormality

  Yang HR. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 71 - 71

• Contactin 2 and contactin-associated protein 2 antibodies in patients with multiple sclerosis and clinically isolated syndrome

  Nytrova P. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 268 - 269

• Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system

  Yang HR. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 317 - 318

• Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.

  Kitley J. et al, (2012), Neurology, 79, 1273 - 1277

• EPILEPSY AND THE IMMUNE SYSTEM " ... IS THERE ANTIBODY THERE? ... ''

  Wright S. et al, (2012), EPILEPSIA, 53, 228 - 229

• Auto-antibodies in adult herpes encephalitis

  Bick S. et al, (2012), EUROPEAN JOURNAL OF NEUROLOGY, 19, 747 - 747

• Morvan syndrome: clinical and serological observations in 29 cases.

  Irani SR. et al, (2012), Ann Neurol, 72, 241 - 255

• Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations.

  Iizuka T. et al, (2012), J Neurol, 259, 1566 - 1573

• Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.

  Kitley J. et al, (2012), Brain, 135, 1834 - 1849

• Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

  Leite MI. et al, (2012), Neurology, 78, 1601 - 1607

• Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

  Kim JS. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 533 - 534

• Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.

  Viegas S. et al, (2012), Exp Neurol, 234, 506 - 512

• Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.

  Becker EB. et al, (2012), J Neurol Neurosurg Psychiatry, 83, 437 - 440

• THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER

  Leite MI. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.

  Saadoun S. et al, (2012), Ann Neurol, 71, 323 - 333

• Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

  Saadoun S. et al, (2012), Annals of Neurology, 71, 323 - 333

• MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• EXPANDING THE PHENOTYPIC SPECTRUM OF PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS SYNDROME (PERMS) ASSOCIATED WITH GLYCINE RECEPTOR ANTIBODY: CLINICAL AND LABORATORY STUDY OF 20 PATIENTS

  Leite MI. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

  Waters PJ. et al, (2012), Neurology, 78, 665 - 671

• Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

  Kitley J. et al, (2012), Brain, 135, 1834 - 1849

• Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.

  Kim SM. et al, (2011), J Neurol, 258, 2176 - 2180

• Antiglycine-receptor encephalomyelitis with rigidity.

  Mas N. et al, (2011), J Neurol Neurosurg Psychiatry, 82, 1399 - 1401

• New serological markers for the differential diagnosis of autoimmune limbic encephalitis

  Wandinger KP. et al, (2011), LaboratoriumsMedizin, 35, 329 - 342

• Prognostic factors in aquaporin-4 antibody-mediated disease: UK and Japanese cohorts

  Kitley J. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S291 - S291

• Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain

  Papadopoulos MC. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S513 - S513

• Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica

  Kitley J. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S281 - S281

• PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS: THE FIRST PAEDIATRIC CASE WITH GLYCINE RECEPTOR ANTIBODIES

  Damasio J. et al, (2011), EUROPEAN JOURNAL OF NEUROLOGY, 18, 32 - 32

• MORVAN'S SYNDROME: CLINICAL AND SEROLOGICAL FINDINGS IN 27 CASES

  Irani SR. et al, (2011), EUROPEAN JOURNAL OF NEUROLOGY, 18, 652 - 652

• IMMUNOTHERAPY-RESPONSIVE STATUS EPILEPTICUS WITH ANTI-GLYCINE RECEPTOR ANTIBODY

  Zuliani L. et al, (2011), EUROPEAN JOURNAL OF NEUROLOGY, 18, 50 - 50

• Autoantibodies associated with diseases of the CNS: new developments and future challenges.

  Vincent A. et al, (2011), Lancet Neurol, 10, 759 - 772

• T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.

  Saadoun S. et al, (2011), J Neuroimmunol, 235, 27 - 32

• Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.

  Irani SR. et al, (2011), Ann Neurol, 69, 892 - 900

• Disease-relevant autoantibodies in first episode schizophrenia.

  Zandi MS. et al, (2011), J Neurol, 258, 686 - 688

• Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.

  Akman-Demir G. et al, (2011), J Neurol, 258, 464 - 470

• Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.

  Yang L. et al, (2011), J Neurol Sci, 301, 71 - 76

• New serological markers for the differential diagnosis of autoimmune limbic encephalitis

  Wandinger K-P. et al, (2011), LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 35, 329 - 342

• Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations

  Iizuka T. et al, (2011), Journal of Neurology, 1 - 8

• Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.

  Jarius S. et al, (2010), J Neurol Sci, 298, 158 - 162

• AQUAPORIN-4 M 23 ISOFORM PROVIDES A MORE SENSITIVE ASSAY FOR AQUAPORIN-4 ANTIBODIES

  Waters P. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E32 - E32

• Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG

  Min JH. et al, (2010), MULTIPLE SCLEROSIS, 16, 1293 - 1293

• Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica

  Kim BJ. et al, (2010), MULTIPLE SCLEROSIS, 16, 1289 - 1290

• Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders

  Min JH. et al, (2010), MULTIPLE SCLEROSIS, 16, 1288 - 1289

• Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.

  Irani SR. et al, (2010), Brain, 133, 2734 - 2748

• Recombinant forms of monomeric and homotrimeric globular regions of human C1q as inhibitors of complement and microglia activation induced by beta-amyloid and familial dementia peptides

  Nayak A. et al, (2010), MOLECULAR IMMUNOLOGY, 47, 2284 - 2285

• Diagnostic use of autoantibodies in myasthenia gravis.

  Leite MI. et al, (2010), Autoimmunity, 43, 371 - 379

• Erratum: Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension (Journal of Neurology (2010) 257 DOI: 10.1007/s00415-010-5499-2)

  Dhungana S. et al, (2010), Journal of Neurology, 257, 1229 - 1230

• Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension.

  Dhungana S. et al, (2010), J Neurol, 257, 1211 - 1212

• N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

  Irani SR. et al, (2010), Brain, 133, 1655 - 1667

• N-methyl-d-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

  Irani SR. et al, (2010), Brain, 133, 1655 - 1667

• Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

  Saadoun S. et al, (2010), Brain, 133, 349 - 361

• Structural characterisation of ligand-binding determinants in human lung surfactant protein D: influence of Asp325.

  Shrive AK. et al, (2009), J Mol Biol, 394, 776 - 788

• PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES

  Viegas S. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT

  Leite MI. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY

  Jacob A. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE

  Irani SR. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.

  Kim SM. et al, (2009), Mult Scler, 15, 1062 - 1068

• Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.

  Min JH. et al, (2009), Mult Scler, 15, 1069 - 1076

• Sjögren's syndrome myelopathy: Spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica

  Kim SM. et al, (2009), Multiple Sclerosis, 15, 1062 - 1068

• Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis.

  Singh M. et al, (2009), Mol Immunol, 46, 2363 - 2369

• Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.

  Viegas S. et al, (2009), J Neurol Neurosurg Psychiatry, 80, 679 - 682

• Differential diagnosis and utility of AQP4-antibody assays in an insidious case of longitudinally extensive transverse myelitis

  Rosellini I. et al, (2009), JOURNAL OF NEUROLOGY, 256, S93 - S94

• Lung surfactant proteins A and D as pattern recognition proteins.

  Waters P. et al, (2009), Adv Exp Med Biol, 653, 74 - 97

• Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

  Jarius S. et al, (2008), Brain, 131, 3072 - 3080

• Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.

  Jarius S. et al, (2008), Brain, 131, 3072 - 3080

• Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica

  Jacobson L. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 186 - 186

• IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica

  Jacob S. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 180 - 181

• Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients

  Akman-Demir G. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 184 - 184

• An experimental mouse model of musk antibody positive myasthenia gravis

  Viegas S. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 164 - 164

• A novel fluorescent immunoprecipitation (FIPA) method to detect antibodies to new targets in antibody-mediated diseases

  Waters P. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 184 - 184

• A novel antigenic target in Morvan's syndrome

  Irani SR. et al, (2008), JOURNAL OF NEUROIMMUNOLOGY, 203, 181 - 181

• Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.

  Hutchinson M. et al, (2008), Neurology, 71, 1291 - 1292

• Seven cases of relapsing myelitis with no identified cause

  Geraldes R. et al, (2008), MULTIPLE SCLEROSIS, 14, S124 - S124

• Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.

  Jarius S. et al, (2008), J Neurol Neurosurg Psychiatry, 79

• Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.

  Waters P. and Vincent A., (2008), Int MS J, 15, 99 - 105

• Antibody to aquaporin-4: serum levels correlate with clinical disease activity

  Jarius S. et al, (2008), MULTIPLE SCLEROSIS, 14, S128 - S128

• Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.

  Mahajan L. et al, (2008), Int Immunol, 20, 993 - 1007

• Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

  Waters P. et al, (2008), Arch Neurol, 65, 913 - 919

• Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

  Jarius S. et al, (2008), Nat Clin Pract Neurol, 4, 202 - 214

• Startling new antibody in an old Irish jumper

  McHugh JC. et al, (2008), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 79, 346 - 346

• NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro

  Jarius S. et al, (2007), MULTIPLE SCLEROSIS JOURNAL, 13, S159 - S159

• Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis

  Jarius S. et al, (2007), MULTIPLE SCLEROSIS JOURNAL, 13, S159 - S159

• Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing

  Jarius S. et al, (2007), MULTIPLE SCLEROSIS, 13, S158 - S158

• A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)

  Waters P. et al, (2007), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78, 1030 - 1030

• C1q and its growing family.

  Ghai R. et al, (2007), Immunobiology, 212, 253 - 266

• Surfactant proteins SP-A and SP-D: structure, function and receptors.

  Kishore U. et al, (2006), Mol Immunol, 43, 1293 - 1315

• Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.

  Roumenina LT. et al, (2005), Biochemistry, 44, 14097 - 14109

• Structural and functional anatomy of the globular domain of complement protein C1q (vol 95, pg 113, 2004)

  Kishore U. et al, (2005), IMMUNOLOGY LETTERS, 101, II - II

• Erratum: Structural and functional anatomy of the globular domain of complement protein C1q (Immunology Letters (2004) 95:2 (113-128) DOI: 10.1016/j.imlet.2004.06.015)

  Kishore U. et al, (2005), Immunology Letters, 101

• C1q and tumor necrosis factor superfamily: modularity and versatility.

  Kishore U. et al, (2004), Trends Immunol, 25, 551 - 561

• Structural and functional anatomy of the globular domain of complement protein C1q.

  Kishore U. et al, (2004), Immunol Lett, 95, 113 - 128

• Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction.

  Kojouharova MS. et al, (2004), J Immunol, 172, 4351 - 4358

• Use of peptide: HLA class II complexes to study specific T cells in autoimmune myasthenia gravis.

  Kishore U. et al, (2003), Ann N Y Acad Sci, 998, 339 - 342

• Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens.

  Singh M. et al, (2003), Immunol Lett, 86, 299 - 307

Key Publications

• Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

  Carvajal-González A. et al, (2014), Brain, 137, 2178 - 2192

• Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study

  Kitley J. et al, (2014), JAMA NEUROLOGY, 71, 276 - 283

• Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

  Waters PJ. et al, (2012), Neurology, 78, 665 - 671

• N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

  Irani SR. et al, (2010), Brain, 133, 1655 - 1667

• Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.

  Hutchinson M. et al, (2008), Neurology, 71, 1291 - 1292

Recent Publications

• Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.

  Kim SM. et al, (2017), Mult Scler, 23, 1104 - 1111

• Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

  Lang B. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 353 - 361

• G2A1B3AA receptor antibodies and their clinical associations.

  Waters PJ. and Irani SR., (2017), Neurology, 88, 1010 - 1011

• Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

  Tackley G. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 165 - 169

• Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

  Juryńczyk M. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 132 - 136